Poster # 2533 Tumour Necrosis Predicts Benefit from Hypoxia-modifying Therapy in High Risk Bladder Cancer.

Presenter: Ananya Choudhury, MD, PhD

About the Presenter:
Consultant and Honorary Clinical Senior Lecturer in Clinical Oncology at The Christie NHS Foundation Trust, Manchester, UK. Research activities: Technical radiotherapy in urology: optimising dose delivery while minimising toxicity Predictive biomarkers for response to radiotherapy in bladder cancer and soft tissue sarcoma
Contact the presenter at:

 View the poster

E-mail a friend about this poster:
Enter email address: